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Abstract
Background: The sensitivity and specificity of two in-house MAC-ELISA assays were tested and compared with the
performance of commercially-available CTK lateral flow rapid test and EUROIMMUN IFA assays for the detection of anti-
Chikungunya virus (CHIKV) IgM. Each MAC-ELISA assay used a whole virus-based antigen derived from genetically distinct
CHIKV strains involved in two chikungunya disease outbreaks in Singapore (2008); a January outbreak strain with alanine at
amino acid residue 226 of the E1 glycoprotein (CHIKV-A226) and a May-to-September outbreak strain that possessed valine
at the same residue (CHIKV-226V). We report differences in IgM detection efficacy of different assays between the two
outbreaks. The sensitivities of two PCR protocols were also tested.
Methods and Findings: For sera from January outbreak, the average detection threshold of CTK lateral flow test, MAC-
ELISAs and EUROIMMUN IFA assays was 3.75, 4.38 and 4.88 days post fever onset respectively. In contrast, IgM detection
using CTK lateral flow test was delayed to more than 7 days after fever onset in the second outbreak sera. However, MAC-
ELISA using CHIKV-226V detected IgM in the second outbreak sera 3.96 days after fever onset, which was approximately one
day earlier compared to the same assay using CHIKV-A226 (4.86 days). Specificity was 100% for both commercial assays, and
95.6% for the in-house MAC-ELISAs. For sensitivity determination of the PCR protocols, the probe-based real time RT-PCR
method was found to be 10 times more sensitive than one based on SYBR Green.
Conclusion: Our findings suggested that the two strains of CHIKV using variants A226 and 226V resulted in variation in
sensitivities of the assays evaluated. We postulated that the observed difference in antigen efficacy could be due to the
amino acid substitution differences in viral E1 and E2 envelope proteins, especially the E1-A226V substitution. This
evaluation demonstrates the importance of appraisal of different diagnostic assays before their application in clinical and
operational settings.
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Introduction
Chikungunya virus (CHIKV) has seen a resurgence in recent
years, with outbreaks being described in Republic of Congo in
2000, La R’eunion in 2005, India, Sri Lanka, Malaysia and
Gabon in 2006, Italy in 2007, Singapore and Thailand in 2008
[1,2,3,4,5,6,7,8,9]. The current pandemic involves a newer
CHIKV strain of the East-Central South African (ECSA)
genotype. Extensive research and analysis demonstrated the role
of a viral mutation, A226V, in the changed epidemiology of the
disease. There is no evidence that this particular mutation caused
any alteration in virulence of the CHIKV or clinical manifesta-
tions of the disease, but the mutation, residing in the viral envelop
protein, has been shown to facilitate enhanced transmissibility of
the virus by Aedes (Ae.) albopictus. Several sophisticated studies have
established that the A226V mutation rendered higher viral
replication and dissemination rates in Ae. albopictus, and thus
shortening the extrinsic incubation period in the vector [10,11].
The length of extrinsic incubation period determines the infective
life span of a vector, and consequently has great influence on the
epidemic potential of the virus-vector partnership.
Since 2006, in response to the outbreaks in the region, the
Environmental Health Institute (EHI), a national public health
laboratory in Singapore, has initiated laboratory surveillance for
CHIKV. Two main outbreaks were detected: the first occurring in
January 2008 was a small outbreak with 13 local cases [12,13]; and
the second commenced in May 2008 and peaked two months
later, resulting in 231 local cases by the end of September 2009
[13].
Phylogenetic analysis concluded that viruses isolated from these
two outbreaks were related to the ECSA genotype [13].
Interestingly, the viruses from the first outbreak showed alanine
www.plosntds.org 1 July 2010 | Volume 4 | Issue 7 | e753at amino acid residue 226 (A226) of E1 gene and those from the
second outbreak showed valine (226V) at the same codon. While
Ae. aegypti was the implicated vector in the first outbreak, Ae.
albopictus was the confirmed vector of the second outbreak [13].
Though CHIKV was not isolated from any field caught Ae. aegypti
during the first outbreak, entomological investigations in the
affected area found only Ae. aegypti adults, and data from routine
surveillance (part of Singapore dengue control programme) also
showed that Ae. aegypti was the predominant species in the area.
On the other hand, CHIKV was isolated from Ae. albopictus caught
during the second outbreak.
Laboratory confirmation of CHIKV infection is critical,
especially in dengue endemic areas, as clinical symptoms of the
two diseases are similar. However the two viruses may be
transmitted by different vectors (Ae. aegypti and Ae. albopictus),
which require different control strategies. RT-PCR is an excellent
tool for the early phase confirmation of CHIKV infections, and
many protocols have been established for this purpose
[13,14,15,16,17,18,19,20,21]. Unfortunately, this viral detection
method is limited to the viraemic phase, which is usually one to
five days after fever onset. Thereafter, confirmation of CHIKV
infection requires serological tests. In recent years, a few
commercial CHIKV diagnostic kits have emerged in the market,
but there are very few reports on the systematic and comparative
evaluation of these commercial products. The most recent
CHIKV diagnostic assay on the market is the indirect immuno-
fluorescence assay (IFA) from EUROIMMUN AG (Lu ¨beck,
Germany), whose IgM assay presented a specificity of 98.3%
and a sensitivity of 96.9% [22]. This assay, together with an IgM
lateral flow rapid test kit by CTK Biotech Inc (San Diego, USA),
was evaluated alongside an in-house IgM Capture Enzyme-Linked
Immunosorbant Assay (MAC-ELISA). Sensitivities, specificities
and approximate time antibodies first became detectable in an
infected patient were determined. A comparison between the
sensitivity of two PCR protocols was also performed using RNA
standards derived from cell-cultured viruses. The evaluation, using
samples from two independent and epidemiologically distinct
CHIKV outbreaks in Singapore, was done to establish diagnostic
capability in the laboratory. The IgM titres were not determined,
and thus the kinetics of the antibody has not been established.
However, the availability of a reliable assay allows antibodies to be
titred for each sample, and thus facilitating an ongoing antibody
kinetics study, that will be reported later.
Materials and Methods
Data and Sample Collection
Environmental Health Institute is a public health laboratory that
functions as a licensed diagnostic laboratory, with an ISO9001
accreditation. It served as the national reference laboratory during
the CHIKV outbreaks in 2008. The three diagnostic techniques
were evaluated using three characterized panels of sera.
Persons with an acute febrile illness, signs or symptoms
compatible with chikungunya fever (fever, joint pain, or rash)
were tested with CHIKV RT-PCR [12], a routine test which has
been offered under EHI’s quality assured programme as required
for the national license. Sera panel A and B were multiple
consecutive samples collected from RT-PCR CHIKV confirmed
patients, during the first and second CHIKV outbreaks respec-
tively (See supporting information ‘‘Supporting Data S1’’). The
patients were warded at the Tan Tock Seng Hospital Commu-
nicable Disease Centre (TTSH CDC). The first samples were
collected on the day of first medical consultation and subsequently,
more samples were collected as the disease progressed, till
convalescence. The daily samples were used to determine the
sensitivity of IgM serology on each day of illness.
Panel A, comprising residual blood from eight CHIKV-
confirmed patients from the first outbreak (January 2008), were
collected for clinical management and to determine when the
patient could be discharged. Six to 11 samples were collected from
each patient, resulting in a total of 60 samples (See supporting
information ‘‘Supporting Figure S1’’).
Panel B, from the second outbreak (May to September 2008)
was collected from 28 CHIKV-confirmed patients in August 2008
prospectively. Each patient had five to 12 samples collected,
leading to a total of 225 samples.
All sera samples were kept at 4uC after phlebotomy, transported
on ice, and reached the laboratory within 24 hours. The samples
were either tested on the same day, or stored at 280uC until testing.
Panel C sera were used for specificity tests and consisted of 45
flavivirus-confirmed sera (44 Dengue, one Japanese Encephalitis)
and five non-CHIKV alphavirus-confirmed sera (two Barmah
Forest, three Ross River).
Analysts of the serology tests were not blinded to the RT-PCR
results of the first samples. However, they were blinded to the
serology results derived from the other tests.
Ethics Statement
Panels A and C were residual samples of sera sent to EHI for
diagnosis. Use of residual samples for evaluation of diagnostic
assays to establish in-house capability is exempted from internal
review by the National Environment Agency Bioethics Review
Committee. Use of sera panel B, which was collected for a larger
study, was approved by the National Healthcare Group Domain
Specific Review Board, and written informed consent was
obtained from the study participants.
Serological Assays
In-house IgM capture Enzyme-Linked Immunosorbant
Assay (MAC-ELISA). Native, inactivated antigens of CHIKV
Author Summary
Chikungunya is a mounting public health concern in many
parts of the world. Definitive diagnosis is critical in
differentiating the diseases, especially in dengue endemic
areas. There are some commercial chikungunya kits and
published molecular protocols available, but no compre-
hensive comparative evaluation of them was performed.
Using sera collected in outbreaks caused by two variants of
Chikungunya virus (A226 and 226V), we tested 2
commercial IgM tests (CTK lateral flow rapid test and
EUROIMMUN IFA) alongside our in-house IgM assays
(using both variants of the virus). Sensitivities of 2
published PCR protocols were also evaluated based on
RNA standards derived from cell-cultured viruses. The
commercial assays had different performances in each
outbreak, with CTK’s lateral flow test having the best
performance in the first outbreak and EUROIMMUN IFA
being more sensitive in the second outbreak. Use of the
current circulating virus in a test assay improves sensitivity
of the MAC-ELISAs. For PCR, a probe-based real time RT-
PCR method was found to be 10 times more sensitive than
the SYBR Green method. Despite this, the latter protocol is
found to be more suitable and cost-effective for our
diagnostic laboratory. This evaluation demonstrates the
importance of appraisal of commercial kits and published
protocols before application of a diagnostic tool in the
clinical and operational setting.
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[isolate name SG(EHI)CHD122508] isolates from patients were
used for the in-house MAC-ELISA. The former had alanine at
amino acid residue 226 (A226) of E1 gene and the latter, isolated in
the second outbreak, had valine (226V) at the same codon. CHIKV
D67Y08 (A226) and D1225Y08 (226V) were passaged twice
through Vero cells (ATCC No. CCL-81) before their
supernatents were collected and virus titres were determined using
a plaque assay method as previously described [23]. CHIKV
antigens were heat inactivated before use. Supernatant of each
CHIKV strain was diluted with Casein buffer to attain a titre of 10
6
pfu/ml. A single batch of antigen was prepared from each virus.
The same batches of antigens, controls and reagents were utilized
for the entire evaluation. Testing with reference CHIKV IgM
positive serum obtained from the Royal College of Pathologist of
Australasia Quality Assurance Programme (RCPA QAP), yielded
equivalent optical density (OD) values for the two assays with
different viruses, and verified the standardization performed.
However, no calibration with any sera was performed as that
would have eliminated any differences observed for different sera.
The MAC-ELISA was adapted from Taiwan Communicable
Disease Centre, Taipei [personal comm]. All reagents were added
at100 ml perwell.Briefly,96-wellmaxisorp plates (Nunc,Denmark)
were coated overnight at 4uC or one hr at 37uC with 2.6 mg/ml of
goat anti-human IgM Fc5u (Jackson ImmunoResearch, USA) in
sodium bicarbonate (pH 9.5). Wells were then washed once with
washing buffer (PBS and 0.05% Tween-20) and blocked in dilution
buffer (Casein buffer and 0.05% Tween-20) for one hr at 37uC.
Wells were subsequently washed once and 1:100 diluted sera were
added. In each plate, two positive controls, two negative (Dengue
IgM human sera) and one plate control (no sera added) were
included. The two positive controls (CHIKV IgM human sera with
a titre of 1:256) were derived from each outbreak. After incubation
forone hrat37uC,thewellswerewashedsixtimes.CHIKVantigen
(10
6 pfu/ml) was added into each well and incubated for two hrs at
37uC. After washing, 1:50 mouse anti-alphavirus IgG (Santa Cruz
Biotechnology, USA) was added into each well and incubated for
two hrs at 37uC. After subsequent washing, 1:1000 dilution of
peroxidase conjugated rabbit anti-mouse IgG (DAKO, Denmark)
was added into each well and incubated for one hr at 37uC.
Tetramethylbenzidine (TMB) substrate (Sigma, USA) was added
and reaction was stopped with 1N sulphuric acid. Absorbance was
measured at 450 nm against a reference filter at 620 nm.
Cut-off values were derived by using mean 6 standard
deviation OD values of the negative controls. A sample was
considered negative when the OD value was less than the mean
value of the negative control plus two standard deviations,
considered equivocal when the OD value exceeded the mean
value of the negative control plus two standard deviations, but less
than three standard deviations, and considered positive when the
OD value is above three standard deviations. In this study, all
equivocal results were retested.
Commercial kits. Each batch of commercial assays was
checked with a CHIKV IgM positive reference serum obtained
from the RCPA QAP, before usage. Chikungunya IgM IFA from
EUROIMMUN AG (Lu ¨beck, Germany) (catalog no. FI 293a-
1010M) and On-site Chikungunya IgM lateral flow rapid test from
CTK Biotech Inc (San Diego, USA) (catalog no. R0065c) were
utilized according to manufacturers’ instructions. In brief, for
EUROIMMUN IFA, CHIKV IgM serum samples were diluted
1:10 with the diluent buffer provided, and 25 ml of this was used
for each reaction. Eight samples could be run on each slide,
alongside one positive and one negative control. Slides were
incubated for 30 mins at room temperature before washing with
PBS-Tween buffer provided. Then, 20 ml of Fluorescein-labelled
anti-human IgM was added and this was followed by a dark
incubation at room temperature for another 30 mins, before slides
were mounted and visualized under the fluorescence microscope.
A positive reaction occurred when cells fluoresced. For CTK rapid
cassette, 35 ml of a serum sample and a drop of the provided
sample diluent were applied onto the sample well. Each cassette
was incubated at room temperature for 10 mins. A positive
reaction was when the test line appeared alongside the control line.
EUROIMMUN IFA uses the whole virus of CHIKV-A226
[22,24] whereas CTK uses a recombinant antigen that included
alanine at amino acid residue 226 of E1 gene (CHIKV-A226)
[personal comm].
RT-PCR
To determine the sensitivities of PCR protocols, two previously
published protocols were tested. The first was a one-step SYBR
Green based RT-PCR, from Hasebe et al. 2002, for the detection
of a fragment of the non-structural protein 1 (nsP1) gene of
CHIKV [15]. The PCR conditions were described in Hapuar-
achchi et al. 2010. The other assay was a taqman probe-based
RT-PCR protocol adapted from Pastorino et al. 2005, with slight
modifications to the primers which target the E1 region (Table 1)
and included following modifications to the PCR assay: PCR
assay was performed using the Qiagen QuantiTect Probe RT-
PCR kit, in a final reaction volume of 20 mlc o n t a i n i n g5mlo f
template, 16of buffer mix, 0.2 ml of RT enzyme mix, 0.25 mMo f
probe, 0.25 mM and 0.4 mM of forward and reverse primers
respectively. The amplification cycles were extended to 50 with
denaturation at 94uC for 5 sec and annealing/extension step at
60uC for 1 min. The analytical sensitivity and reproducibility of
both assays were determined using 10-fold dilutions of cultured
CHIKV strains D67Y08 (A226) and D1225Y08 (226V)
(2.7610
21 to 2.7610
8 pfu/ml). CHIKV RNA was extracted
from the dilutions using QIAamp viral RNA mini kit (Qiagen,
Hilden, Germany).
Test and Data Analysis
A total of three analysts were involved in the evaluations. The
two commercial IgM assays were performed by one analyst, and
Table 1. Primers and probe sequences of Taqman probe-based RT-PCR assay.
Name Sequence (59R39)
Position (based on full
genome)
Position based on complete E1
gene
Forward Primer (10366F) AAG CTY CGC GTC CTT TAC CAA GGA AA 10366 to 10391 (9952 to 11268bp)
Reverse Primer (10574R) CCA AAT TGT CCT GGT CTT CCT 10574 to 10554 393 to 418
Taqman Probe (P10465) (Fam)CCA ATG TCY TCM GCC TGG ACA CCT TT(TAMRA) 10465 to 10490 581 to 601
doi:10.1371/journal.pntd.0000753.t001
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analyst performed the PCR sensitivity tests. All analysts were
trained in-house, certified by the Director of the diagnostic
laboratory, and regularly passed the external (RCPA) and internal
proficiency tests, under the EHI quality assurance programme.
The sensitivity and specificity of assays were calculated in
Microsoft Excel 2007. ANOVA, to test for variance amongst
results obtained by the serological assays, and Student t-tests to
determine any significant differences between the different assays
were calculated using SPSS 13.0 software.
Results
Average Detection Threshold, Sensitivity and Specificity
of Serological Assays
The commercial lateral flow rapid test and IFA, along with in-
house MAC-ELISAs using both D67Y08 (226A) and D1225Y08
(226V), were evaluatedusing three panels of sera. Sera panels A and
B were collected during the two outbreaks in January and May to
September in 2008 respectively, and were from CHIKV RT-PCR-
confirmed patients (See supporting information ‘‘Supporting Data
S1’’). Average IgM detection threshold, according to day after fever
onset was determined. During the first outbreak, the lateral flow
(CTK) kit enabled the detection of IgM on an average of 3.75 days
after fever onset. IFA (EUROIMMUN) and in-house MAC-ELISA
detected IgM on 4.88 day and 4.38 day respectively. The use of
CHIKV-A226 or -226V did not alter the effectiveness of the in-
house ELISA assays (Table 2) during the January outbreak.
Though CTK’slateral flow assay had thebest performance inthe
January outbreak, its performance was not repeated in the second
outbreak. Among the first 10 CHIKV- confirmed patient sera (total
of 74 samples from Panel B), none had detectable IgM within seven
days after fever onset. The earliest IgM detection attained by the
lateral flow assay, was day nine after the onset of fever (n=1) and
eight of the 10 patients did not show seroconversion even after 14
days. To investigate if the drop in performance was due to batch
variability of the CTK kit, 30 CHIKV-A226 IgM positive and 10
CHIKV negative samples from the first outbreak were retested with
the second batch ofCTK kits. No differencein results interpretation
was observed. As the ineffectiveness of the kit was clearly
demonstrated by the 74 samples from the 10 patients, and both
batches of kits were no longer available, the rest of the samples from
the second outbreak (151 samples from 18 patients) were not tested
with the CTK assay.
Using IFA (EUROIMMUN) and MAC-ELISA (A226) on the
panel collected from the second outbreak, the average day of IgM
detection was 4.86 after fever onset. Interestingly, the use of
CHIKV-226V as antigen in MAC-ELISA increased the sensitivity
to 3.96 day after onset of fever (p,0.0001).
Overall, the sensitivity of assays increased along with the
progression of the disease (Figure 1). Sensitivities of all assays were
very low from day zero to day four of the disease, ranging from 0
to 66.7% (Figure 1a). Sensitivity improved from day five, when
MAC-ELISA (226V) fared the best at 93.94%; followed by MAC-
ELISA (A226) at 84.85%; and IFA (EUROIMMUN) at 75.76%.
Lateral flow (CTK) remained insensitive at 12.12%. By the sixth
day, 100% sensitivity was attained by MAC-ELISA (226V), and
by day seven, MAC-ELISA (A226) and IFA (EUROIMMUN) also
achieved 100%.
In view of the possible variation in sensitivity between the two
outbreaks, the samples from the CHIKV-A226 and CHIK-226V
outbreaks were analysed separately (Figure 1b). In the first
outbreak involving CHIKV-A226, lateral flow (CTK) test was
positive in two out of five samples that were collected one day after
fever onset. The sensitivity steadily increased to 100% by seven
days. The other three assays started to register sensitivities greater
than 50% on day five after fever onset.
In the second outbreak, involving CHIKV-226V, MAC-ELISA
(226V) had the highest sensitivity of 75% at four days after fever
onset and increased to 100% by day six (Figure 1c). IFA
(EUROIMMUN) and MAC-ELISA (A226) detected less than
50% of samples on day four, and attained 100% only on day
seven. It appeared that in the second outbreak, MAC-ELISA
(226V), which utilized the virus isolated in the same outbreak, was
the most sensitive.
Panel C comprising of non-CHIKV sera was utilized to
determine the specificity that turned out to be 100% for both
commercial assays. The sensitivity of in-house MAC-ELISA was
95.6%. The latter picked up two dengue confirmed sera which
were paired samples from a single patient collected 14 days apart.
Though MAC-ELISA yielded positive results with the two
samples, no increase in titre was observed and negative CHIKV
PRNT results were obtained (data not shown).
Determination of Sensitivity of PCR Assays
Two real-time PCR protocols were evaluated on RNAs
extracted from a serial dilution of each of the cell-cultured viruses,
D67Y08 (A226) and D1225Y08 (226V), isolated from the two
Table 2. Average detection threshold: Day after onset of fever when IgM was detectable by the evaluated techniques.
Average day (range of days) of IgM detection after fever onset
Lateral flow (CTK) IFA (EUROIMMUN) MAC-ELISA (A226) MAC-ELISA (226V)
Panel A- January Outbreak (n=60) 3.75
a (1–7) 4.88
a(3–6) 4.38
a(2–5) 4.38
a(2–5)
Panel B- May–September Outbreak
(n=225*)
.7
* (9–40) 4.86
b,c(2–7) 4.86
b,d(2–7) 3.96
b,c,d(2–6)
Overall ND 4.86 4.75 4.06
The day of IgM detection was calculated based on sequential samples collected from eight patients in the first outbreak (n=60), and from 28 patients in the second
outbreak (n=225), and is the mean of the days in which IgM was first picked up by the various assays. For evaluation of CTK assay in the second outbreak, only samples
from the first ten patients were used (n=74).
aVariance between assays, as calculated by ANOVA, demonstrated no significant difference p=0.56.
bVariance between assays, as calculated by ANOVA, demonstrated significant difference p=0.003 (CTK lateral flow was disregarded in the analysis).
cT-test showed significant difference between IFA(EUROIMMUN) and MAC-ELISA (226V) p,0.0001.
dT-test showed significant difference between MAC-ELISAs (226V) and (A226) (p,0.0001.
*Only 10 patients and their subsequent samples were tested.
doi:10.1371/journal.pntd.0000753.t002
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using RNA from isolated virus, no patient samples were used for
this purpose. The sensitivities of each protocol for both viruses
were equivalent. However, the sensitivity of the taqman probe-
based protocol was found to be 10 times (2.17610
0 pfu/ml) more
than the SYBR Green assay (2.17610
1 pfu/ml) (Table 3). The
inverse relationship of Cp values and virus titres showed very good
linear correlation between the detection of CHIKV-A226 and -
226V when either assays were used (Figure 2).
Discussion
As dengue and chikungunya infections elicit similar symptoms
and can be present in the same locations, clinical differentiation
may be difficult. In Singapore, it was found that the major
chikungunya outbreak in the second half of 2008 was transmitted
by Ae. albopictus, an outdoor mosquito. Control of chikungunya
fever was thus different from the strategy employed for control of
dengue fever, which is transmitted by Ae. aegypti, a peri-
domesticated mosquito. It is thus important to ascertain the cause
of a cluster of febrile illness. This study was carried out to ensure
that accurate and robust diagnostic tools were used to diagnose
chikungunya fever in Singapore.
Our findings suggested that two variants of CHIKV, A226 and
226V, had resulted in variation in sensitivities of the assays
evaluated. Though CTK’s lateral flow rapid test was found to be a
reliable kit in the first outbreak (January 2008), it was ineffective in
the second ((May to September 2008). Retesting a panel of
CHIKV characterized samples from the first outbreak showed that
the inconsistency was not a result of batch variation. We
postulated that the inconsistency may be due to the different
CHIKV variants involved in two outbreaks. The CTK rapid test
kit used a recombinant antigen covering the 226 residue of E1
gene derived from the CHIKV-A226 [personal comm.], which
was similar to the strain involved in the first outbreak. It is thus
suggested that CHIKV-A226 derived recombinant antigen was
specific for recognition by antibodies elicited by the A226 virus
circulating during the first outbreak, but not for those elicited
against the 226V virus of the second outbreak. Therefore, it is
highly likely that the sensitivity of the rapid test can be improved
by including the recombinant antigen derived from the variant
virus.
The variation in sensitivity of an assay due to different antigens
used was also demonstrated by our in-house MAC-ELISA, where
CHIKV-226V antigens yielded higher sensitivity than CHIKV-
A226, when tested on sera obtained from patients infected with the
CHIKV-226V strain. Similarly, the decrease in sensitivity of the
EUROIMMUN IFA was probably attributed to the use of
CHIKV-A226 [22,24]. The less striking sensitivity differences in
these assays may be attributed to the use of whole viruses that offer
more epitopes for recognition. Interestingly, both A226 and 226V
viral strains offered the same sensitivity among samples collected
from the first outbreak (A226). Notwithstanding the latter
observation, our results indicated that sensitivity of a test could
be improved by using the circulating virus isolated during a
particular outbreak. It is unlikely that the difference in sensitivity
was due to differences in quality of the antigen, as a single batch of
antigen was prepared from each virus and yet, sera from the two
outbreaks were giving different results for the A226 antigen (but
not for the 226V antigen). Both antigens were prepared in the
same way, and all sera were tested in one experiment using the
same reagents and controls. Our results suggest the disadvantage
of using a recombinant antigen that is too specific.
The commercial assays displayed excellent specificity, but the
in-house ELISAs picked up two paired dengue IgM samples.
These samples did not demonstrate increase in CHIKV IgM titres,
Figure 1. Longitudinal variation of the sensitivity of IgM assays in the first seven days after fever onset. 1a: overall sensitivity based on
samples collected from first and second chikungunya fever outbreaks in January and May to September 2008, respectively; 1b: sensitivity based on
samples collected from the first outbreak due to CHIKV-A226 strain; 1c: sensitivity based on samples collected from the second outbreak due to
CHIKV-226V strain. The numbers in brackets along the x-axis represent the number of samples tested for each day after onset of fever.
doi:10.1371/journal.pntd.0000753.g001
Table 3. Sensitivity of each CHIKV RT-PCR assay: SYBR Green and Taqman probe-based on PFU per reaction and PFU/ml of cell-
culture supernatants of CHIKV D67Y08 and D1225Y08.
Pfu/reaction Pfu/ml CHIKV-A226 CHIKV-226V
SYBR Green (Cp value)
Taqman probe
based (Cp value) SYBR Green (Cp value)
Taqman probe based
(Cp value)
10
5 2.17610
7 11.01 14.94 14.57 14.87
10
4 2.17610
6 15.17 18.47 16.57 17.89
1000 2.17610
5 19.17 21.11 20.21 23.82
100 2.17610
4 23.78 24.29 23.84 27.45
10 2.17610
3 28.16 27.55 29.94 29.60
1 2.17610
2 31.15 30.25 .35 31.11
0.1 2.17610
1 32.18 33.36 .35 36.55
0.01 2.17610
0 Not detectable 37.15 Not detectable 38.68
0.001 2.17610
21 Not detectable 40.51 Not detectable .45
Amplification graphs were checked for cross-point (Cp) value of the PCR product. Cp represented the cycle by which the fluorescence of a sample increased to a level
higher than the background fluorescence in the amplification cycle. Melting curve analysis was performed after amplification with the SYBR Green protocol, to ensure
that the right product was amplified. No differences in sensitivies were observed when both PCR protocols were tested on either virus. Melting peak was not detected
in the SYBR Green assay when less than 0.1 pfu of virus was used in each reaction. However, the probe-based protocol could detect up to 0.01 pfu per reaction. Cp value
above 40 is not reliable, and is thus reported as equivocal.
doi:10.1371/journal.pntd.0000753.t003
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Dengue and Chikungunya co-infected samples, rather a false
positive due to non-specific IgM reactions. In our experience with
dengue diagnosis, this phenomenon is not unknown, especially
among adults who suffer from conditions such as Systemic Lupus
Erythematosus or other immunological conditions. Though the
phenomenon is poorly understood, we believe that false positives
in IgM serology could be due to other immunological factors, and
this may also be the case for CHIKV infection. The cross reaction
may not be due to Dengue virus cross- reacting with the CHIKV
assay. Our investigation and analysis in Singapore using
geographical information system had also revealed that Singa-
pore’s major outbreak, due to CHIKV-226V and Aedes albopictus,
did not overlap spatially with dengue fever, which is transmitted by
Ae. aegypti. The likelihood of co-infection in Singapore was thus
assessed to be very low.
A comparison of the amino acid sequences of the non-structural
and structural polyproteins of D67Y08 (A226) and D1225Y08
(226V) isolates revealed 5 amino acid substitutions in the non-
structural polyprotein and 4 in the structural polyprotein (Table 4).
The A226V substitution was the only variation in the E1 envelope
protein and the remaining 3 amino acid substitutions in the
structural polyprotein were in E2 envelope protein. At the same
time, among the 162 epitopes predicted by the Kolaskar &
Tongaonkar algorithm in JEMBOSS (ANTIGENIC) version 1.5
[25], only 2 epitopes coincided with the amino acid differences
observed in the structural polyprotein between DS67Y08
(CHIKV-A226) and DS1225Y08 (CHIKV-226V) isolates. Those
amino acid substitutions were at residues 677 (E2 envelope
protein) and 1035 (A226V in E1 envelope protein) of the structural
polyprotein. Though the epitope was similar for both isolates at
residue 677, the programme predicted different configurations for
the two viral variants at residue 1035 (A226V). CHIKV-226V had
a single linear, 34 amino acids long (amino acid positions 1019–
1052) epitope, while CHIKV-A226 had 2 short epitopes flanking
the same region: a 15 amino acid epitope (amino acid positions
1019–1033) and a 18 amino acid epitope (amino acid positions
1035–1052). Based on these observations, we hypothesized that
the structural differences due to the A226V variation may have
resulted in 226V antigen being more specific to the paratope of
IgM of sera infected with the variant (226V) virus. In the absence
of other recognition epitopes, a recombinant E1 antigen with
A226 could have much reduced affinity to antibodies produced
against the 226V variant, thus rendering a test that relies on an
inappropriate A226 E1 gene ineffective during an outbreak
involving CHIKV-226V strain.
Using whole virus as antigen (as in the case of MAC-ELISA and
EUROIMMUN IFA) offers more antibody recognition sites. As a
result, the difference in sensitivity affected by CHIKV-A226 and
226V as antigens was not very prominent. However, as E1 and E2
envelope proteins exist as a heterodimer on the alphavirus surface,
contribution of amino acid substitutions in the E2 protein to the
observed differences between two antigens could not be underes-
timated and will be of future interest.
The sensitivity of each RT-PCR protocol was not altered by the
virus used. However, the probe-based PCR protocol was at least
10 times more sensitive than the SYBR Green assay. Nevertheless,
the SYBR Green method was maintained as the routine test at
Figure 2. Inverse relationship of Cp values with virus titre when 2 PCR protocols using CHIKV-A226 and -226V were evaluated. Both
assays, when tested on CHIKV-A226 and -226V, indicate excellent linear reliability between the decrease of Cp values and the increase in virus titre.
doi:10.1371/journal.pntd.0000753.g002
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Green assay was half of that of the probe-based; 2) the SYBR
Green assay took 30 minutes, while the probe-based assay
required 2.5 hours; and 3) the SYBR Green assay was sensitive
enough for routine diagnosis of acute cases. Our previous study
has shown that the SYBR Green method was able to detect viral
RNA after resolution of fever in 30% of cases [12]. The method
also detected three asymptomatic viraemic cases, one day prior to
their onset of fever [13]. Taken together, it was concluded that the
SYBR method was a cost effective tool for the diagnosis and
surveillance of chikungunya fever.
The kinetics of viraemia in patient samples were previously
examined and high levels of viraemia were observed during the
first 5 days of illness [12]. Combining previous molecular findings
[12] and current serology findings, medical practitioners in
Singapore have been encouraged to request for PCR-based assays
for patients who present within five days of fever and IgM assays
for those with fever for more than 5 days. We have found that both
EUROIMMUN IFA and MAC-ELISA assays were suitable for
outbreaks involving both A226 and 226V variant viruses. For IgM
test, MAC-ELISA has the advantage of being cost effective and
easy to perform, whereas commercial EUROIMMUN IFA is
suitable in laboratories with limited capacity for setting up in-
house ELISA systems. An improved rapid test would benefit the
community too. For PCR, the SYBR Green protocol was cost
effective for the diagnosis of acute patients. This study demon-
strates the importance of evaluation of commercial kits and
published protocols before application of a diagnostic tool in the
clinical and operational settings. With a cost effective and reliable
in-house ELISA assay, as demonstrated in this study, the time
course of IgM in CHIKV infected individuals is currently being
investigated.
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